Search for: "ML " Results 141 - 160 of 2,699
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jun 2010, 3:01 pm by Oliver G. Randl
An insulin preparation according to claim 15, comprising: 0.5 to 4.0 mg/ml, preferably 0.6 to 4.0 mg/ml, of m-cresol or 0.5 to 4.0 mg/ml, preferably 1.4 to 4.0 mg/ml, of phenol, or a mixture thereof.Independent claim 1 of the main request read:1. [read post]
6 Dec 2009, 7:41 pm by Matt Johnston
To be fair, I think MLS has faced one crisis and come through pretty well. [read post]
21 Oct 2018, 9:59 pm by Patent Docs
EPO Becomes First Authority to Release Guidance Specific to Eligibility of AI/ML By Aaron Gin -- Artificial intelligence (AI) and machine learning (ML) are specifically addressed in new draft Guidelines for Examination (Guidance) released earlier this month from the European Patent Office (EPO). [read post]
The key findings of the survey include: ML is increasingly being used in UK financial services with two thirds of respondents already using ML in some form; in many cases, ML development has passed the initial development phase and is entering more advanced stages of development. [read post]
31 Oct 2019, 11:25 am by Barbara S. Mishkin
  We look at how changes in consumer behavior have impacted collections, technology’s role in collections, state law’s/GDPR’s impact on ML/AI and compliance strategies, how ML/AI can improve profitability, and perceived impediments to adopting ML/AI. [read post]
14 Sep 2009, 10:27 am
Ives Galarcep asks the question: Should MLS suspend players for diving? [read post]
17 Mar 2022, 8:45 am by Simon Lovegrove (UK)
AI/ML model governance structures, including responsibilities and accountability for AI/ML-driven decisions. [read post]
31 Jan 2021, 10:00 pm
Here we highlight FDA’s current regulatory scheme for AI/ML-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
31 Jan 2021, 10:00 pm
Here we highlight FDA’s current regulatory scheme for AI/ML-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
31 Jan 2021, 10:00 pm
Here we highlight FDA’s current regulatory scheme for AI/ML-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
31 Jan 2021, 10:00 pm
Here we highlight FDA’s current regulatory scheme for AI/ML-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
31 Jan 2021, 10:00 pm
Here we highlight FDA’s current regulatory scheme for AI/ML-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
31 Jan 2021, 10:00 pm
Here we highlight FDA’s current regulatory scheme for AI/ML-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
1 Apr 2019, 5:15 am by Robert Tarcu
The below analysis reviews the recent developments by the EPO and the USPTO to provide specific guidance on the topic of AI and ML. [read post]
21 Aug 2008, 4:01 pm
I hope this plan will help bring an MLS franchise to St. [read post]